Chinese CRO Adopts Medidata CTMS
R&G provides a full range of clinical trial services for both domestic and global partners.
R&G Pharma Studies, a Beijing, China-based CRO, has broadened its adoption of Medidata's Clinical Cloud, becoming the first Chinese customer to use Medidata CTMS.® R&G provides a full range of clinical trial services-including regulatory affairs, clinical monitoring, data management capabilities, biostatistics, pharmacoeconomics, site management organization (SMO) services, and staffing and outsourcing-supporting studies on both a global and domestic scale.
Read the full release.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
